Myrbetriq and Zelboraf drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported only by a few people who take Myrbetriq and Zelboraf together.
The phase IV clinical study analyzes what interactions people who take Myrbetriq and Zelboraf have. It is created by eHealthMe based on reports of 3 people who take the same drugs from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
3 people who take Myrbetriq and Zelboraf together, and have interactions are studied.
What is Myrbetriq?
Myrbetriq has active ingredients of mirabegron. It is often used in urge incontinence. eHealthMe is studying from 28,494 Myrbetriq users for its effectiveness, alternative drugs and more.
What is Zelboraf?
Zelboraf has active ingredients of vemurafenib. eHealthMe is studying from 8,112 Zelboraf users for its effectiveness, alternative drugs and more.
Number of Myrbetriq and Zelboraf reports submitted per year:
Common Myrbetriq and Zelboraf drug interactions by gender *:
Common Myrbetriq and Zelboraf drug interactions by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Myrbetriq and Zelboraf?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of the 2 drugs:
Browse all drug interactions of Myrbetriq and Zelboraf:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Myrbetriq side effects:
- Drug ineffective: 5,359 reports
- High blood pressure: 2,196 reports
- Fatigue (feeling of tiredness): 1,483 reports
- Headache (pain in head): 1,477 reports
- Dizziness: 1,407 reports
- Urinary tract infection: 1,293 reports
- Diarrhea: 1,158 reports
- Constipation: 1,125 reports
Browse all side effects of Myrbetriq:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Zelboraf side effects:
- Rashes (redness): 1,624 reports
- Death: 1,005 reports
- Fatigue (feeling of tiredness): 934 reports
- Joint pain: 922 reports
- Diarrhea: 605 reports
- Hair loss: 520 reports
- Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat): 507 reports
Browse all side effects of Zelboraf:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Myrbetriq interactions:
- Myrbetriq and Aspirin: 2,613 reports
- Myrbetriq and Vitamin d: 2,390 reports
- Myrbetriq and Gabapentin: 2,062 reports
- Myrbetriq and Omeprazole: 1,658 reports
- Myrbetriq and Vitamin d3: 1,499 reports
- Myrbetriq and Lisinopril: 1,369 reports
- Myrbetriq and Metformin: 1,290 reports
- Myrbetriq and Amlodipine: 1,260 reports
- Myrbetriq and Pantoprazole: 1,220 reports
- Myrbetriq and Baclofen: 1,191 reports
Browse all interactions between Myrbetriq and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Zelboraf interactions:
- Zelboraf and Cotellic: 1,355 reports
- Zelboraf and Aspirin: 142 reports
- Zelboraf and Omeprazole: 126 reports
- Zelboraf and Prednisone: 117 reports
- Zelboraf and Pantoprazole: 114 reports
- Zelboraf and Lisinopril: 104 reports
- Zelboraf and Metformin: 102 reports
Browse all interactions between Zelboraf and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on mirabegron and vemurafenib (the active ingredients of Myrbetriq and Zelboraf, respectively), and Myrbetriq and Zelboraf (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Myrbetriq and Zelboraf.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Omega-3 and Deep Venous Thrombosis - now
- Skyrizi and Metabolic Disorder - 3 seconds ago
- Luvox and Seizures - 3 seconds ago
- Serzone and Urinary Incontinence Aggravated - 7 seconds ago
- Escitalopram Oxalate vs. Tranylcypromine Sulfate - 10 seconds ago
- Migraine With Aura and High Blood Pressure - 23 seconds ago
- Dexmedetomidine Hydrochloride and Muscle Spasms - 24 seconds ago
- Zolpidem Tartrate and Diffuse Panbronchiolitis - 30 seconds ago
- Rosuvastatin Calcium and Zoledronic drug interaction - 31 seconds ago
- Relafen and Platelet Count Increased - 33 seconds ago